Modulation of the locomotor responses induced by D 1 -like and D 2 -like dopamine receptor agonists and D-amphetamine by NMDA and non-NMDA glutamate receptor agonists and antagonists in the core of the rat nucleus accumbens

By David H.N.   Sissaoui K.   Abraini J.H.  

Neuropharmacology, Vol. 46, Iss. 2, 2004-02 ,pp. : 179-191

Elsevier

Access to resources Recommend Favorite

Dopamine receptor agonists in the therapy of Parkinson’s disease

By Foley P.   Gerlach M.   Double K. L.   Riederer P.  

Journal of Neural Transmission, Vol. 111, Iss. 10-11, 2004-10 ,pp. : 1375-1446

Springer Publishing Company

Access to resources Recommend Favorite

Postsynaptic dopamine (D 2 )-mediated behavioural effects of high acute doses of artemisinin in rodents

By Amos S.   Chindo B.A.   Abbah J.   Vongtau H.O.   Edmond I.   Binda L.   Akah P.A.   Wambebe C.   Gamaniel K.S.  

Brain Research Bulletin, Vol. 62, Iss. 3, 2003-12 ,pp. : 255-260

Elsevier

Access to resources Recommend Favorite

Dopamine Receptor Agonists Mediate Neuroprotection in Malonate-Induced Striatal Lesion in the Rat

By Armentero M-T.   Fancellu R.   Nappi G.   Blandini F.  

Experimental Neurology, Vol. 178, Iss. 2, 2002-12 ,pp. : 301-305

Academic Press

Access to resources Recommend Favorite

Combined 5-HT 1A and 5-HT 1B receptor agonists for the treatment of l-DOPA-induced dyskinesia

By Muñoz Ana  

Brain, Vol. 131, Iss. 12, 2008-12 ,pp. : 3380-3394

Oxford University Press

Access to resources Recommend Favorite